ENTRY       D02572                      Drug
NAME        Viloxazine hydrochloride (USAN);
            Qelbree (TN);
            Vivalan (TN)
PRODUCT     QELBREE (Supernus Pharmaceuticals)
FORMULA     C13H19NO3. HCl
EXACT_MASS  273.1132
MOL_WEIGHT  273.7558
CLASS       Neuropsychiatric agent
             DG03085  Selective norepinephrine reuptake inhibitor (NRI)
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
              DG03187  UGT2B15 substrate
REMARK      ATC code: N06AX09
            Chemical structure group: DG00956
            Product (DG00956): D02572<US>
EFFICACY    Antidepressant, Selective noradrenaline reuptake inhibitor (NRI)
  DISEASE   Attention deficit hyperactivity disorder [DS:H01895]
TARGET      SLC6A2 (NAT1) [HSA:6530] [KO:K05035]
  PATHWAY   hsa04721(6530)  Synaptic vesicle cycle
METABOLISM  Enzyme: CYP2D6 [HSA:1565], UGT1A9 [HSA:54600], UGT2B15 [HSA:7366]
INTERACTION  
STR_MAP     map07027  Antidepressants
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AX Other antidepressants
                 N06AX09 Viloxazine
                  D02572  Viloxazine hydrochloride (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Attention Deficit Hyperactivity Disorder Agents, Non-amphetamines
               Viloxazine
                D02572  Viloxazine hydrochloride (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00956  Viloxazine
                D02572  Viloxazine hydrochloride
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00956  Viloxazine
                D02572  Viloxazine hydrochloride
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                DG00956  Viloxazine
                 D02572  Viloxazine hydrochloride
               DG03187  UGT2B15 substrate
                DG00956  Viloxazine
                 D02572  Viloxazine hydrochloride
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC6
                SLC6A2 (NAT1)
                 D02572  Viloxazine hydrochloride (USAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02572
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02572
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02572
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG03085  Selective norepinephrine reuptake inhibitor (NRI)
               DG00956  Viloxazine
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00956  Viloxazine
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                DG00956  Viloxazine
               DG03187  UGT2B15 substrate
                DG00956  Viloxazine
DBLINKS     CAS: 35604-67-2
            PubChem: 17396743
            LigandBox: D02572
            NIKKAJI: J262.760D
ATOM        18
            1   C8x C    12.6000  -17.0800
            2   C8x C    12.6000  -15.6800
            3   C8x C    13.7900  -14.9800
            4   C8y C    15.0500  -15.6800
            5   C8y C    15.0500  -17.0800
            6   C8x C    13.7900  -17.7800
            7   O2a O    16.2400  -17.7800
            8   C1b C    17.5000  -17.0800
            9   C1y C    18.6900  -17.7800
            10  O2a O    16.2400  -14.9800
            11  C1b C    17.5000  -15.6800
            12  C1a C    18.6900  -14.9800
            13  O2x O    19.8800  -17.0800
            14  C1x C    21.1400  -17.7800
            15  C1x C    21.1400  -19.1800
            16  N1x N    19.8800  -19.8800
            17  C1x C    18.6900  -19.1800
            18  X   Cl   24.7800  -16.6600
BOND        18
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 1
            10    4  10 1
            11   10  11 1
            12   11  12 1
            13    9  13 1
            14   13  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18    9  17 1
///
